| mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |